These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2111283)

  • 1. Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.
    Little SF; Leppla SH; Friedlander AM
    Infect Immun; 1990 Jun; 58(6):1606-13. PubMed ID: 2111283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin.
    Little SF; Leppla SH; Cora E
    Infect Immun; 1988 Jul; 56(7):1807-13. PubMed ID: 3384478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies.
    Little SF; Novak JM; Lowe JR; Leppla SH; Singh Y; Klimpel KR; Lidgerding BC; Friedlander AM
    Microbiology (Reading); 1996 Mar; 142 ( Pt 3)():707-715. PubMed ID: 8868446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.
    Gubbins MJ; Berry JD; Corbett CR; Mogridge J; Yuan XY; Schmidt L; Nicolas B; Kabani A; Tsang RS
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):436-43. PubMed ID: 16872381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
    Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the immune response to the lethal toxin of Bacillus anthracis].
    Belova EV; Kolesnikov AV; Zakharova MIu; Dubileĭ SA; Diatlov IA; Shemiakin IG
    Bioorg Khim; 2008; 34(5):639-44. PubMed ID: 19060938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
    Tang Q; Xiong S; Liang X; Kuai X; Wang Y; Wang C; Feng Z; Zhu J
    BMC Infect Dis; 2018 Dec; 18(1):640. PubMed ID: 30526504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.
    Reason D; Liberato J; Sun J; Camacho J; Zhou J
    Toxins (Basel); 2011 Aug; 3(8):979-90. PubMed ID: 22069752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis.
    Kulshreshtha P; Bhatnagar R
    Mol Immunol; 2011 Sep; 48(15-16):1958-65. PubMed ID: 21704379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin.
    Zhou B; Carney C; Janda KD
    Bioorg Med Chem; 2008 Feb; 16(4):1903-13. PubMed ID: 18023190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of three exotoxic factors of Bacillus anthracis by sequential immunosorbent chromatography.
    Larson DK; Calton GJ; Little SF; Leppla SH; Burnett JW
    Toxicon; 1988; 26(10):913-21. PubMed ID: 3144059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.
    Mohamed N; Li J; Ferreira CS; Little SF; Friedlander AM; Spitalny GL; Casey LS
    Infect Immun; 2004 Jun; 72(6):3276-83. PubMed ID: 15155630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1.
    Rivera J; Nakouzi A; Abboud N; Revskaya E; Goldman D; Collier RJ; Dadachova E; Casadevall A
    Infect Immun; 2006 Jul; 74(7):4149-56. PubMed ID: 16790789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.
    Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB
    J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro].
    Belova EV; Dubileĭ SA; Kravchenko TB; Kolesnikov AV; Zakharova MIu; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2004; (3):21-6. PubMed ID: 15354937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.